RECRUITING

EyeConic: Qualification for Cone-Optogenetics

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

Official Title

Qualification for Cone-Optogenetics (EyeConic)

Quick Facts

Study Start:2021-07-01
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05294978

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Lucas Janeschitz-Kriegl, MD
CONTACT
+41787494373
lucas.janeschitz@iob.ch
Daniela Hauenstein
CONTACT
+41612658718
daniela.hauenstein@usb.ch

Principal Investigator

Nicolas Feltgen, MD
PRINCIPAL_INVESTIGATOR
University Hospital Basel/Institute of Molecular and Clinical Ophthalmology Basel, Switzerland

Study Locations (Sites)

University of California San Francisco, Department of Ophthalmology
San Francisco, California, 94158
United States
Bascom Palmer Eye Institute
Miami, Florida, 33136
United States
University of Pittsburgh, Department of Ophthalmology
Pittsburgh, Pennsylvania, 15213
United States

Collaborators and Investigators

Sponsor: University Hospital, Basel, Switzerland

  • Nicolas Feltgen, MD, PRINCIPAL_INVESTIGATOR, University Hospital Basel/Institute of Molecular and Clinical Ophthalmology Basel, Switzerland

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-01
Study Completion Date2025-12

Study Record Updates

Study Start Date2021-07-01
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Cone-Optogenetics
  • Rod-cone Dystrophy
  • Cone-rod Dystrophy
  • Generalized retinal dystrophies
  • Inherited retinal disease

Additional Relevant MeSH Terms

  • Retinal Dystrophies